Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
1.4%
1w
3.2%
1m
7.1%
3m
11.7%
6m
23.2%
1y
33.2%
all
6.4%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 149 1.4%
132
169
Company Overview
Sales
8,871 Cr
Growth: 1.7%
Profit after Tax
-184 Cr
Growth: 314.5%
Mid Cap
19,746 Cr
P/S: 2.2x
Industry P/S: 2.4x
Fundamentals
Sales (Cr) ₹ 8,871
Growth 1.7%
EBITDA 11.5%
P/S 2.2x
Dividend 0.1%
P/E -119.8x
Book Value ₹ 58.6
PEG Ratio -72.3x
ROE -2.3%
P/B 2.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (31 Indices) view more
Investors (6)
vskr63
chethan3
ravi_kum...
Followers (2)
saurabh8...
varsha96